Sort by
Refine Your Search
-
Category
-
Employer
-
Field
-
of gene therapy manufacturing and process innovation. The project focuses on the development and optimization of scalable bioprocesses for viral vector production and downstream purification and
-
14 Jul 2026 Job Information Organisation/Company Université Catholique de Louvain (UCL) Department Institute for Language and Communication Research Field Communication sciences Researcher Profile
-
algorithms capable of operating in large, partially observed spatial domains to infer efficient, interpretable strategies for estimating archaeological potential, that capture distinct criteria including
-
, operational, and societal constraints. The postdoc will work at the interface of reinforcement learning and computational epidemiology, focusing on the development of new reinforcement learning algorithms
-
prospection with the FLAIR's strengths in developing new multi-objective deep reinforcement learning algorithms, to support decision makers under uncertainty. VUB team:Prof. dr. Ralf Vandam (AMGC), Prof. dr
-
simulation methods and scientific software development. The successful candidate will contribute to research and development on: EMT simulation of future power systems. Simulation methods for converter
-
developing generic tools that take a declarative problem description and automatically compute an optimal solution to it. Often, users specify their problem in a high-level, human-understandable formal
-
constraints. The postdoc will work at the interface of reinforcement learning and computational epidemiology, focusing on the development of new reinforcement learning algorithms. The project will consider
-
antiviral target-discovery by uncovering this terra incognita. To that end, we developed high-throughput, multiplex, high-content multiparametric phenotypic antiviral assays. These allow to screen hundreds
-
position The Laboratory of Causal Systems Immunology is looking for a PhD student or postdoctoral researcher to advance in vivo perturbational screening. We have developed single-cell CRISPR technologies